Imaging biomarkers for Duchenne muscular dystrophy

Thesis: S.M., Massachusetts Institute of Technology, School of Engineering, Center for Computational Engineering, Computation for Design and Optimization Program, 2015. === Cataloged from PDF version of thesis. === Includes bibliographical references (pages 75-78). === Duchenne muscular dystrophy (D...

Full description

Bibliographic Details
Main Author: Koppaka, Sisir
Other Authors: Brian W. Anthony.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2017
Subjects:
Online Access:http://hdl.handle.net/1721.1/106959
id ndltd-MIT-oai-dspace.mit.edu-1721.1-106959
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-1069592019-05-02T15:54:56Z Imaging biomarkers for Duchenne muscular dystrophy Imaging biomarkers for DMD Koppaka, Sisir Brian W. Anthony. Massachusetts Institute of Technology. Computation for Design and Optimization Program. Massachusetts Institute of Technology. Computation for Design and Optimization Program. Computation for Design and Optimization Program. Thesis: S.M., Massachusetts Institute of Technology, School of Engineering, Center for Computational Engineering, Computation for Design and Optimization Program, 2015. Cataloged from PDF version of thesis. Includes bibliographical references (pages 75-78). Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood and affects 1 in 3600 male births. The disease is caused by mutations in the dystrophin gene leading to progressive muscle weakness which ultimately results in death due to respiratory and cardiac failure. Accurate, practical, and painless tests to diagnose DMD and measure disease progression are needed in order to test the effectiveness of new therapies. Current clinical outcome measures such as the sixminute walk test and North Star Ambulatory Assessment (NSAA) can be subjective and limited by the patient's degree of effort and cannot be accurately performed in the very young or severely affected older patients. We propose the use of image-based biomarkers with suitable machine learning algorithms instead. We find that force-controlled (precise acquisition at a certain force) and force-correlated (acquisition over a force sweep) ultrasound helps to reduce variability in the imaging process. We show that there is a high degree of inter-operator and intra-operator reliability with this integrated hardware-software setup. We also discuss how other imaging biomarkers, segmentation algorithms to target specific subregions, and better machine learning techniques may provide a boost to the performance reported. Optimizing the ultrasound image acquisition process by maximizing the peak discriminatory power of the images vis-à-vis force applied at the contact force is also discussed. The techniques presented here have the potential for providing a reliable and non-invasive method to discriminate, and eventually track the progression of DMD in patients. by Sisir Koppaka. S.M. 2017-02-16T16:43:52Z 2017-02-16T16:43:52Z 2015 2015 Thesis http://hdl.handle.net/1721.1/106959 936560020 eng MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission. http://dspace.mit.edu/handle/1721.1/7582 78 pages application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Computation for Design and Optimization Program.
spellingShingle Computation for Design and Optimization Program.
Koppaka, Sisir
Imaging biomarkers for Duchenne muscular dystrophy
description Thesis: S.M., Massachusetts Institute of Technology, School of Engineering, Center for Computational Engineering, Computation for Design and Optimization Program, 2015. === Cataloged from PDF version of thesis. === Includes bibliographical references (pages 75-78). === Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood and affects 1 in 3600 male births. The disease is caused by mutations in the dystrophin gene leading to progressive muscle weakness which ultimately results in death due to respiratory and cardiac failure. Accurate, practical, and painless tests to diagnose DMD and measure disease progression are needed in order to test the effectiveness of new therapies. Current clinical outcome measures such as the sixminute walk test and North Star Ambulatory Assessment (NSAA) can be subjective and limited by the patient's degree of effort and cannot be accurately performed in the very young or severely affected older patients. We propose the use of image-based biomarkers with suitable machine learning algorithms instead. We find that force-controlled (precise acquisition at a certain force) and force-correlated (acquisition over a force sweep) ultrasound helps to reduce variability in the imaging process. We show that there is a high degree of inter-operator and intra-operator reliability with this integrated hardware-software setup. We also discuss how other imaging biomarkers, segmentation algorithms to target specific subregions, and better machine learning techniques may provide a boost to the performance reported. Optimizing the ultrasound image acquisition process by maximizing the peak discriminatory power of the images vis-à-vis force applied at the contact force is also discussed. The techniques presented here have the potential for providing a reliable and non-invasive method to discriminate, and eventually track the progression of DMD in patients. === by Sisir Koppaka. === S.M.
author2 Brian W. Anthony.
author_facet Brian W. Anthony.
Koppaka, Sisir
author Koppaka, Sisir
author_sort Koppaka, Sisir
title Imaging biomarkers for Duchenne muscular dystrophy
title_short Imaging biomarkers for Duchenne muscular dystrophy
title_full Imaging biomarkers for Duchenne muscular dystrophy
title_fullStr Imaging biomarkers for Duchenne muscular dystrophy
title_full_unstemmed Imaging biomarkers for Duchenne muscular dystrophy
title_sort imaging biomarkers for duchenne muscular dystrophy
publisher Massachusetts Institute of Technology
publishDate 2017
url http://hdl.handle.net/1721.1/106959
work_keys_str_mv AT koppakasisir imagingbiomarkersforduchennemusculardystrophy
AT koppakasisir imagingbiomarkersfordmd
_version_ 1719030405122752512